FDA’s Device Labeling Proposed Rule Misses The Mark, Industry Says
This article was originally published in The Gray Sheet
Executive Summary
While device firms say FDA’s proposed rule on symbols in device labeling is needed, they say additional requirements for explanations of symbols in an accompanying glossary are duplicative.
You may also be interested in...
FDA Finalizes Device Symbol-In-Labeling Rule Retaining Glossary Requirement
Industry complaints that a 2013 FDA proposal calling for a glossary explanation for standalone symbols used in device labels went beyond internationally harmonized standards did not persuade the agency to drop the glossary from its June 14 final rule, but FDA does provide more flexibility on symbols that can be employed in device labeling.
FDA Outlines Next Steps For Online Repository And Standard Elements For Device Labeling
Industry representatives, health care providers, patients and caregivers gathered April 29-30 to discuss CDRH labeling activities and the agency’s ideas for the future.
FDA Proposes Rule On Symbols In Device Labeling
By allowing for the inclusion of stand-alone standardized symbols on medical device labeling, FDA seeks to harmonize U.S. regulatory requirements with those of the European Commission.